2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by BONOMINI, M. Articles by ARDUINI, A. Search for Related Content PubMed PubMed Citation Articles by BONOMINI, M. Articles by ARDUINI, A.

Increased Erythrocyte Phosphatidylserine Exposure in Chronic Renal Failure

MARIO BONOMINI^*, VITTORIO SIROLLI^*, NICOLA SETTEFRATI^*, SECONDO DOTTORI, LORENZO DI LIBERATO^* and ARDUINO ARDUINI

^* Institute of Nephrology, Department of Medicine, "G. d'Annunzio" University, Chieti, Italy
Department of Metabolism and Endocrinology, Sigma-Tau, Pomezia, Rome, Italy.

Correspondence to Dr. Mario Bonomini, Institute of Nephrology, San Camillo de Lellis Hospital, Via Forlanini, 66100 Chieti, Italy. Phone and Fax: +39 0871 41405; E-mail: m.bonomini{at}nephro.unich.it

Abstract

Abstract. The appearance of phosphatidylserine, an aminophospholipid normally confined to the inner monolayer, at the outer leaflet of red cell membrane may have several pathophysiologic implications. This study examines erythrocyte phosphatidylserine exposure in chronic renal failure (CRF) patients on conservative treatment or on dialysis, to assess possible alterations to phospholipid asymmetry in a condition associated with a state of deranged red cell function. A significant increase in phosphatidylserine-expressing erythrocytes was found in undialyzed patients with CRF (2.32%) and patients on hemodialysis (3.06%) and on peritoneal dialysis (2.14%) compared with control subjects (0.68%). In undialyzed CRF patients, a strong correlation (r = 0.903) was found between the percentage of phosphatidylserine-expressing red cells and the serum creatinine concentration. The increased exposure of phosphatidylserine in uremic erythrocytes may be due to inhibition of phosphatidylserine transport from the outer to the inner leaflet of plasma membrane and may promote an increased erythrophagocytosis. In reconstitution experiments, normal erythrocytes showed an increase in phosphatidylserine-expressing cells when incubated in uremic plasma (3.2% after 2 h versus 1.1% at beginning of incubation), whereas phosphatidylserine-positive uremic erythrocytes decreased when resuspended in normal plasma (2.03% after 2 h and 1.65% after 8 h versus 2.9% at beginning of incubation). Preliminary characterization of the putative uremic compound(s) indicates a molecular weight between 10,000 and 20,000, as well as heat instability. These findings show an impairment of erythrocyte membrane phospholipid asymmetry in CRF patients, regardless of the dialysis treatment. Such abnormality seems related to the uremic state and could contribute to the red cell pathology present in CRF.

This article has been cited by other articles:

				B. N. Y. Setty and S. G. Betal Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytes Blood, January 15, 2008; 111(2): 905 - 914. [Abstract] [Full Text] [PDF]

				M. Minetti, L. Agati, and W. Malorni The microenvironment can shift erythrocytes from a friendly to a harmful behavior: Pathogenetic implications for vascular diseases Cardiovasc Res, July 1, 2007; 75(1): 21 - 28. [Abstract] [Full Text] [PDF]

				M Piagnerelli, K Zouaoui Boudjeltia, D Brohee, A Vereerstraeten, P Piro, J-L Vincent, and M Vanhaeverbeek Assessment of erythrocyte shape by flow cytometry techniques J. Clin. Pathol., May 1, 2007; 60(5): 549 - 554. [Abstract] [Full Text] [PDF]

				D. Mandal, A. Mazumder, P. Das, M. Kundu, and J. Basu Fas-, Caspase 8-, and Caspase 3-dependent Signaling Regulates the Activity of the Aminophospholipid Translocase and Phosphatidylserine Externalization in Human Erythrocytes J. Biol. Chem., November 25, 2005; 280(47): 39460 - 39467. [Abstract] [Full Text] [PDF]

				M. Bonomini, V. Sirolli, G. Merciaro, T. Antidormi, L. Di Liberato, U. Brummer, M. Papponetti, P. Cappelli, P. Di Gregorio, and A. Arduini Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine Nephrol. Dial. Transplant., February 1, 2005; 20(2): 361 - 366. [Abstract] [Full Text] [PDF]

				M. Bonomini, E. Ballone, S. Di Stante, T. Bucciarelli, S. Dottori, A. Arduini, A. Urbani, and V. Sirolli Removal of uraemic plasma factor(s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells Nephrol. Dial. Transplant., January 1, 2004; 19(1): 68 - 74. [Abstract] [Full Text] [PDF]

				S. Myssina, S. M. Huber, C. Birka, P. A. Lang, K. S. Lang, B. Friedrich, T. Risler, T. Wieder, and F. Lang Inhibition of Erythrocyte Cation Channels by Erythropoietin J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2750 - 2757. [Abstract] [Full Text] [PDF]

				K. de Jong, S. K. Larkin, L. A. Styles, R. M. Bookchin, and F. A. Kuypers Characterization of the phosphatidylserine-exposing subpopulation of sickle cells Blood, August 1, 2001; 98(3): 860 - 867. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673